Page 62 - Genetic Engineering News Today

Havana, Mar 31 (Prensa Latina) The final stage of the clinical trial of the Mambisa Covid-19 vaccine candidate, the only homegrown devised to be nasally administered, is about to end, media reported Thursday.

Clinical trials of the Mambisa intranasal vaccine against Covid-19 are in progress and the developers will apply "in the coming weeks" for authorization to administer the drug as a booster, Cuban Comm. Cuba conducts clinical trials of nasal Covid-19 vaccine | World | English edition | Agencia EFE

Havana, Mar 31 (EFE).- Clinical trials of the Mambisa intranasal vaccine against Covid-19 are in progress and the developers will apply “in the coming weeks” for authorization to administer the drug as a booster, Cuban Communist Party daily Granma said Thursday. Cuba’s Center for Genetic Engineering and Biotechnology (CIGB), the creators of Mambisa, says that …

Researchers at InBio (formerly Indoor Biotechnologies), a biotech company in Virginia, report progress en route to developing a hypoallergenic cat – or at least treating patients with allergies to the domestic cat – in a new article published online in The CRISPR Journal.

Today the U.S. Environmental Protection Agency (EPA) approved the use of Corteva herbicide products Enlist One and Enlist Duo in all Missouri counties. A seven-year registration announced by EPA in January 2022 had restricted the use of Enlist One and Enlist Duo weed management options in five Missouri counties (Barton, Bates, Cedar, St.

The Chicago Biomedical Consortium (CBC) launched the inaugural class of the CBC Entrepreneurial Fellows program to help train the next generation of Chicago bio-entrepreneurs.

Havana, Mar 26 (Prensa Latina) President Miguel Diaz-Canel on Saturday highlighted the international acknowledgement of Cuba's Covid-19 vaccine creators, who will receive the Medal for Inventors, awarded by the World Intellectual Property Organization (WIPO).

An obscure species of wild grass contains “blockbuster” disease resistance that can be cross bred into wheat to give immunity against one of the deadliest crop pathogens.

Antibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COVID-19, according to a study published in the peer-reviewed journal Viral Immunology.

BANGKOK - Thailand is pushing to downgrade from pandemic status within three months after having some coronavirus travel restrictions lifted recently.